Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use

Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use

US Patent 12428425 · Granted Sep 30, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of APOL1 and methods of using same2025
Treprostinil derivative compounds and methods of using same2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2025